Ohio Administrative Code › Title 5122 - Department of Mental Health and Addiction Services › Chapter 5122-2 - Grievances; Death; Psychotropic Medication; Etc › Section 5122-2-13 - Medication practices in regional psychiatric hospitals

Current through all regulations passed and filed through July 1, 2024
(A) The purpose of
			 this rule is to ensure safe and quality patient
			 care by establishing standards that govern all aspects of medication practices
			 within inpatient settings of the regional
			 psychiatric hospitals (RPHs). Medication practices 
								will reaffirm
			 patients' rights to receive appropriate medication treatment and
			  participate actively in treatment
			 decisions.
(B) The following
			 definitions  apply to this rule in
			 addition to those specified in
			 rule
			 5122-1-01 of the
			 Administrative Code:
(1) "Administration"
			 means the direct application of a single drug to the body of a patient either
			 by injection, inhalation, ingestion, or any other means.
(2)
									"Certified pharmacy technician" means an individual who is
			 registered with the state board of pharmacy as a certified pharmacy technician
			 under section
			 4729.901 of
			 the Revised Code.
(3) "Chief
			 clinical officer" and "CCO" mean the medical director of an RPH as defined in
			 division (K) of section
			 5122.01
			 of the Revised Code.
(4)
			 "Computerized physician order entry" and "CPOE" mean the computer program by
			 which a  prescriber can order a medication.
(5) "Dispensing" refers to the final
			 association of a medication with a particular patient pursuant to a lawful
			 prescription of a  prescriber, and assuming responsibility for the activities
			 involved in filling the prescription.
(6) "Emergency" means an impending or crisis
			 situation which creates circumstances demanding immediate actions for
			 prevention of injury to the patient or others, as determined either by a
			 physician ,
			 registered nurse, or physician
			 assistant.
(7) "Hazardous
			 medication" means a medication that is potentially genotoxic, carcinogenic,
			 teratogenic, or can cause developmental toxicity if improperly handled. A list of these
			 medications is published by the national
			 institute for occupational safety and health of the United States centers for
			 disease control and prevention and updated as
			 needed.
(8) "High risk
			 medication" means a medication that has an increased risk of causing significant pertinent
			 harm or death if it is misused or used in error.
(9) "Informed consent" means a process that
			 requires a prescriber to give a patient or legal guardian all information
			 necessary to make an informed decision to either undergo or refuse a proposed
			 treatment or medication, including the following components: nature of the
			 treatment or medication; the potential benefits, risks
			 , or
			 possible side effects or consequences associated with taking or not agreeing to
			 the recommended treatment or medication; any alternative treatments available
			 to the patient; and determination that the patient has the capacity to give or
			 withhold informed consent.
(10)
									"Medication" or "drug" means a natural or chemical
			 substance that exerts a pharmacological
			 effect intended  for the purpose of treatment,
			 prevention, or diagnostic studies of illness.
(11) "Medication reconciliation" means the
			 gathering of data on medications that were prescribed prior to admission and
			 using the data in the selection of medications that are prescribed during the
			 patient's hospital stay. Upon discharge
			 or transfer, a list of medications currently prescribed is also shared
			 with the next provider of services.
(12) "Medication with abuse potential" means
			 a controlled
			 substance as defined in section 802(6) of the " Controlled Substances
			 Act," 
										21
			 U.S.C. 802(6), as
			 amended, or a noncontrolled medication with recognized potential
			 for abuse.
(13)
									"Pharmacist" means a person licensed under Chapter
			 4729. of the Revised Code to engage in the practice of pharmacy.
(14)
									"Physician"
			 means a person licensed under Chapter 4731. of the Revised Code to practice
			 medicine and surgery or osteopathic medicine and surgery.
(15)
			 "Prescriber" has the same meaning
			 as in section
			 4729.01
			 of the Revised Code, except that it excludes a veterinarian licensed under
			 Chapter 4741. of the Revised Code.
(16)
			 "Prescribing" means an order for one or more
			 medications issued.
(17) "PRN order" means
			 an order for a medication that is given only when a patient manifests a
			 specific clinical condition and consents to take the medication.
(18)
			 "Prescription drug" means a medication  dispensed only upon a prescriptionor includes on the manufacturer's
			 label the wording, "Rx only," or the statement, "Caution: federal
			 law prohibits dispensing without prescription."
(19) "Psychotropic
			 medication" means a medication
			 that has
			 specific and intended effects on 
			 central nervous system functions and 
			 is ordinarily used to treat disorders
			 of thought, perception, mood, or behavior.
(20) "Standing orders"
			 means an established, routine, or special order from a prescriber and approved by
			 the CCOthat is applicable to the general population of a
			 unit,
			 ward, or RPH as opposed to an individual.
(21) "Telephone order"
			 means an order transmitted by telephone.
(22) "Verbal order"
			 means an order spoken aloud by a prescriber in the presence of the person
			 authorized to receive the order.
(23) "Verification"
			 means the professional clinical review of a patient's medication profile by a
			 pharmacist for dose, schedule, medication allergies, drug-drug interactions,
			 drug-food interactions, and drug-disease interactions prior to the dispensing
			 of a new medication.